When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

ADARx Pharmaceuticals upsized its IPO and raised additional cash through a private placement with partner AbbVie. Lead ADARx program onvuzosiran is in Phase 3 testing for the rare disease hereditary ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health ...

The question is whether these AI tools will be another fragmented layer of technology or true assistants to help them spend ...

Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView ...

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

Amgen’s dazodalibep led to statistically significant and clinically meaningful results, according to preliminary Phase 3 ...